Mariola Söhngen
Chief Executive Officer bei PROTEOME SCIENCES PLC
Profil
Mariola Söhngen was the founder of Bootcamp (1999) and PAION AG (2000), where she held the title of Chief Medical Officer from 2011 to 2015.
She is also the founder of Paion Deutschland GmbH.
Currently, she is the Chief Executive Officer & Director at Proteome Sciences Plc since 2020.
Previously, she worked as the Chief Executive Officer at Convert Pharmaceuticals SA from 2018 to 2019, Head-Research & Development at MOLOGEN AG from 2015 to 2018, Manager at Grünenthal GmbH from 1988 to 1996, and Head-Clinical Research at Trommsdorff GmbH & Co. KG from 1997 to 1998.
She also served as a Member-Supervisory Board at Vita 34 AG and as a Scientist at Fachhochschule Düsseldorf.
Dr. Söhngen received her undergraduate and doctorate degrees from RWTH Aachen University.
Aktive Positionen von Mariola Söhngen
| Unternehmen | Position | Beginn |
|---|---|---|
| PROTEOME SCIENCES PLC | Chief Executive Officer | 15.09.2020 |
Ehemalige bekannte Positionen von Mariola Söhngen
| Unternehmen | Position | Ende |
|---|---|---|
Convert Pharmaceuticals SA
 Convert Pharmaceuticals SA Miscellaneous Commercial ServicesCommercial Services Convert Pharmaceuticals SA provides preclinical stage drug development services. Its product hypoxia activated prodrug (HAP) is a therapeutic obstacle as it promotes the development of resistance to conventional anti-cancer treatments. The company was founded by Philippe Lambin, Nicolas Geuens, and Paul Tulcinsky on February 24, 2017 and is headquartered in Liege, Belgium. | Chief Executive Officer | 01.12.2019 |
| MOLOGEN AG | Chief Executive Officer | 31.07.2018 |
| PAION AG | Founder | 31.10.2015 |
Trommsdorff GmbH & Co. KG
 Trommsdorff GmbH & Co. KG Pharmaceuticals: MajorHealth Technology Trommsdorff GmbH & Co. KG engages in the manufacture, development, and distribution of pharmaceuticals, as well as nutritional and dietary supplements. It also sells medical equipment and devices. The company is headquartered in Alsdorf, Germany. | Chief Tech/Sci/R&D Officer | 01.01.1998 |
Grünenthal GmbH
 Grünenthal GmbH Pharmaceuticals: MajorHealth Technology Grünenthal GmbH engages in the research and development of pharmaceutical products. It specializes in pain, gout, and inflammation. The company was founded by Hermann Wirtz in 1946 and is headquartered in Aachen, Germany. | Corporate Officer/Principal | 01.01.1996 |
Ausbildung von Mariola Söhngen
| RWTH Aachen University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| PAION AG | Health Technology |
| PROTEOME SCIENCES PLC | Health Technology |
| MOLOGEN AG | Commercial Services |
| VITA 34 AG | Health Technology |
| Private Unternehmen | 6 |
|---|---|
Grünenthal GmbH
Grünenthal GmbH Pharmaceuticals: MajorHealth Technology Grünenthal GmbH engages in the research and development of pharmaceutical products. It specializes in pain, gout, and inflammation. The company was founded by Hermann Wirtz in 1946 and is headquartered in Aachen, Germany. | Health Technology |
Paion Deutschland GmbH
 Paion Deutschland GmbH BiotechnologyHealth Technology Paion Deutschland GmbH engages in the development of pharmaceutical products. The company is headquartered in Aachen, Germany. | Health Technology |
Trommsdorff GmbH & Co. KG
Trommsdorff GmbH & Co. KG Pharmaceuticals: MajorHealth Technology Trommsdorff GmbH & Co. KG engages in the manufacture, development, and distribution of pharmaceuticals, as well as nutritional and dietary supplements. It also sells medical equipment and devices. The company is headquartered in Alsdorf, Germany. | Health Technology |
Convert Pharmaceuticals SA
Convert Pharmaceuticals SA Miscellaneous Commercial ServicesCommercial Services Convert Pharmaceuticals SA provides preclinical stage drug development services. Its product hypoxia activated prodrug (HAP) is a therapeutic obstacle as it promotes the development of resistance to conventional anti-cancer treatments. The company was founded by Philippe Lambin, Nicolas Geuens, and Paul Tulcinsky on February 24, 2017 and is headquartered in Liege, Belgium. | Commercial Services |
| Bootcamp | |
W. Söhngen GmbH
 W. Söhngen GmbH Medical SpecialtiesHealth Technology W. Söhngen GmbH engages in the development, production, and distribution of medical kits. It offers products for wound care as well as first aid and emergency medicine. The company is headquartered in Taunusstein, Germany. | Health Technology |
